Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Bolla

Showing results (91-100 of 256) with videos related to

Pageof 26
Sort By:
Breast Cancer Research : BCR|November 24, 2022
Correction: PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patientsDaniele Giardiello, Maartje J Hooning, Michael Hauptmann, et al.
Breast Cancer (Tokyo, Japan)|May 11, 2022
Relevance of the MHC region for breast cancer susceptibility in AsiansPeh Joo Ho, Alexis Jiaying Khng, Benita Kiat-Tee Tan, et al.
Molecular Genetics & Genomic Medicine|May 9, 2019
The functional ALDH2 polymorphism is associated with breast cancer risk: A pooled analysis from the Breast Cancer Association ConsortiumTomotaka Ugai, Roger L Milne, Hidemi Ito, et al.
Ebiomedicine|October 21, 2019
Re-evaluating genetic variants identified in candidate gene studies of breast cancer risk using data from nearly 280,000 women of Asian and European ancestryYaohua Yang, Xiang Shu, Xiao-Ou Shu, et al.
European Journal of Epidemiology|October 3, 2023
Polymorphisms in genes of melatonin biosynthesis and signaling support the light-at-night hypothesis for breast cancerKatharina Wichert, Reiner Hoppe, Katja Ickstadt, et al.
International Journal of Cancer|July 4, 2017
Gene-environment interactions involving functional variants: Results from the Breast Cancer Association ConsortiumMyrto Barrdahl, Anja Rudolph, John L Hopper, et al.
Endocrine-Related Cancer|October 2, 2013
Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: a genome-wide interaction studyAnja Rudolph, Rebecca Hein, Sara Lindström, et al.
Journal of the National Cancer Institute|November 25, 2024
Childhood, adolescent, and young adulthood cancer risk in BRCA1 or BRCA2 pathogenic variant carriersShuai Li, Laura Madanat-Harjuoja, Goska Leslie, et al.
International Journal of Epidemiology|January 10, 2018
Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association ConsortiumAnja Rudolph, Minsun Song, Mark N Brook, et al.
Genome Medicine|May 8, 2026
The contribution of rare germline variants to the immune landscape of breast cancerFelipe Rojas-Rodríguez, Sander Canisius, Renske Keeman, et al.
Pageof 26

Showing results (91-100 of 256) with videos related to

Sort By:
Pageof 26
Breast Cancer Research : BCR|November 24, 2022
Correction: PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patientsDaniele Giardiello, Maartje J Hooning, Michael Hauptmann, et al.
Breast Cancer (Tokyo, Japan)|May 11, 2022
Relevance of the MHC region for breast cancer susceptibility in AsiansPeh Joo Ho, Alexis Jiaying Khng, Benita Kiat-Tee Tan, et al.
Molecular Genetics & Genomic Medicine|May 9, 2019
The functional ALDH2 polymorphism is associated with breast cancer risk: A pooled analysis from the Breast Cancer Association ConsortiumTomotaka Ugai, Roger L Milne, Hidemi Ito, et al.
Ebiomedicine|October 21, 2019
Re-evaluating genetic variants identified in candidate gene studies of breast cancer risk using data from nearly 280,000 women of Asian and European ancestryYaohua Yang, Xiang Shu, Xiao-Ou Shu, et al.
European Journal of Epidemiology|October 3, 2023
Polymorphisms in genes of melatonin biosynthesis and signaling support the light-at-night hypothesis for breast cancerKatharina Wichert, Reiner Hoppe, Katja Ickstadt, et al.
International Journal of Cancer|July 4, 2017
Gene-environment interactions involving functional variants: Results from the Breast Cancer Association ConsortiumMyrto Barrdahl, Anja Rudolph, John L Hopper, et al.
Endocrine-Related Cancer|October 2, 2013
Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: a genome-wide interaction studyAnja Rudolph, Rebecca Hein, Sara Lindström, et al.
Journal of the National Cancer Institute|November 25, 2024
Childhood, adolescent, and young adulthood cancer risk in BRCA1 or BRCA2 pathogenic variant carriersShuai Li, Laura Madanat-Harjuoja, Goska Leslie, et al.
International Journal of Epidemiology|January 10, 2018
Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association ConsortiumAnja Rudolph, Minsun Song, Mark N Brook, et al.
Genome Medicine|May 8, 2026
The contribution of rare germline variants to the immune landscape of breast cancerFelipe Rojas-Rodríguez, Sander Canisius, Renske Keeman, et al.
Pageof 26